2025. gada publikācijas
1 Q1 · IF 41,9
Saad, F., Vjaters, E., Testa, I., & Haresh, K. P. (2025). Reply to: Inferior Control Arms in Prostate Cancer Trials: The ARANOTE Trial. Journal of Clinical Oncology, 43(11), 1394–1395.
2 Q1 · IF 41,9
Shore, N. D., Saad, F., Vjaters, E., Olmos, D., Littleton, N., Liu, A., Testa, I., Mo, M., Srinivasan, S., & Haresh, K. P. (2025). Darolutamide plus ADT in patients with metastatic hormone-sensitive prostate cancer (mHSPC) by disease volume: Subgroup analysis of the phase 3 ARANOTE trial. Journal of Clinical Oncology, 43(5_SUPPL), 151.
3 Q1 · IF 35,9
Montagna, G., Alvarado, M., Myers, S., microNAC Study Group, & Maksimenko, J. (2026). Oncological outcomes with and without axillary lymph node dissection in patients with residual micrometastases after neoadjuvant chemotherapy (OPBC-07/microNAC): an international, retrospective cohort study. The Lancet Oncology, 27(1), 57–67.
4 IF 13,4
Razis, E., Gorlia, T., Preusser, M., … Valeinis, E., … Hau, P. (2025). European NeuroOncology Quality Assessment (ENOQUA): A European Organization for the Research and Treatment of Cancer (EORTC) Brain Tumor Group Research Project. Neuro-Oncology Practice. Publicēts 2025. gada oktobrī.
5 Q1 · IF 9,0
Sgrò, A., EuroSurg Collaborative, STARSurg Collaborative, Ozoliņš, A., Vjaters, E., Jain, N., Apse, R. R., Apse, I. A., & Truškovs, A. (2025). Extended pharmacological thromboprophylaxis and clinically relevant venous thromboembolism after major abdominal and pelvic surgery: international, prospective, propensity score-weighted cohort study. British Journal of Surgery, 112(3), 1–18. Article znaf005.
6 Q1 · IF 6,2
Hendricks, L. A. J., Verbeek, K. C. J., Schuurs-Hoeijmakers, J. H. M., de Jong, M. M., Links, T. P., Brems, H., Aerden, M., Brunet, J., Lleuger-Pujol, R., Hüneburg, R., Aretz, S., Colas, C., Villy, M. C., Woodward, E. R., Evans, D. G., Bosch, D. G. M., Donze, S. H., Foretová, L., Blatnik, A., Irmejs, A., ... Vos, J. R. (2025). The risk of a second primary cancer in PTEN Hamartoma Tumor Syndrome (PHTS). Genetics in Medicine, 27(10), Article 101467.
7 Q1 · IF 6,2
Saad, F., Briganti, A., Haresh, K. P., Vjaters, E., Olmos, D., Littleton, N., Testa, I., Srinivasan, S., Verholen, F., & Shore, N. (2025). A Deep Prostate-specific Antigen Response to Darolutamide plus Androgen Deprivation Therapy Is Associated with Better Clinical Outcomes in the Phase 3 ARANOTE Trial in Patients with Metastatic Hormone-sensitive Prostate Cancer. European Urology Oncology, 8(5), 1321–1332.
8 Q1 · IF 6,2
Saad, F., Haresh, K. P., Shore, N. S., Vjaters, E., Olmos, D., Littleton, N., Testa, I., Srinivasan, S., Verholen, F., & Briganti, A. (2025). Prostate-Specific Antigen (PSA) response with darolutamide plus Androgen-Deprivation Therapy (ADT) in patients with Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) in ARANOTE. European Urology, 87(Suppl. 2), Article GC11.
9 Q1 · IF 6,2
Niedra, H., Peculis, R., Saksis, R., Mandrika, I., Vilisova, S., Nazarovs, J., Breiksa, A., Gerina, A., Earl, J., Ruz-Caracuel, I., Rosas, M. G., Pukitis, A., Senterjakova, N., & Rovite, V. (2025). Tumor and α-SMA-expressing stromal cells in pancreatic neuroendocrine tumors have a distinct RNA profile depending on tumor grade. Molecular Oncology, 19(3), 659–681.
10 Q1 · IF 5,9
Shore, N., Haresh, K. P., Vjaters, E., Olmos, D., Littleton, N., Testa, I., Srinivasan, S., Verholen, F., & Saad, F. (2025). Ultra-low PSA response (<0.02 ng/ml) with darolutamide plus ADT in ARANOTE correlates with greatly improved clinical outcomes. Journal of Urology, 213(5S, Suppl.), e1360. Article IP26-07.
11 Q1 · IF 5,9
Trinh, Q.-D., George, D. J., Shore, N., Vjaters, E., Olmos, D., Gomes, A. J. P. D. S., Mota, A. C. D. A., Littleton, N., Srinivasan, S., Verholen, F., Haresh, K. P., & Saad, F. (2025). Efficacy and Safety of Darolutamide Plus Androgen-deprivation Therapy (ADT) in Black Patients with Metastatic Hormone-sensitive Prostate Cancer (mHSPC) From the Phase 3 ARANOTE Trial. Journal of Urology, 213(5S Suppl.), e578. Article MP16-01.
12 Q2 · IF 5,4
Monreal, M., Brenner, B., Gómez-Cuervo, C., Dally, N., Alda-Lozano, A., Pesce, M. L., Alfonso-Megido, J., Hernández-Borge, J., Mao, R. L. E., Prandoni, P., RIETE Investigators, & Skride, A. (2025). Comparative safety of enoxaparin versus other low-molecular-weight heparins in cancer-associated venous thromboembolism: a real-world cohort study from RIETE. Research and Practice in Thrombosis and Haemostasis, 9(8), Article 103244.
13 IF 5,2
Fišere, I., Edelmers, E., Svirskis, Š., & Groma, V. (2025). Utilisation of Deep Neural Networks for Estimation of Cajal Cells in the Anal Canal Wall of Patients with Advanced Haemorrhoidal Disease Treated by LigaSure Surgery. Cells, 14(7), 550.
14 Q1 · IF 5,2
Bariševs, M., & Vjaters, E. (2025). Allele-Specific CG/CCWGG Methylation of the PSA Promoter Discriminates Aggressive, Indolent, and Benign Prostate Cell Lines and is Involved in the Regulation of PSA Expression. International Journal of Molecular Sciences, 26(3), Article 1243.
15 Q2 · IF 3,4
Loža, P., Irmejs, A., Daneberga, Z., Maksimenko, J., Trofimovičs, G., Subatniece, S., Gronwald, J., Lubinski, J., & Gardovskis, J. (2025). The difference in contralateral breast cancer and ovarian cancer risks for BRCA1 founder variant (c.5266dup, c.4035del) carriers with primary breast cancer. BMC Cancer, 25(1), Article 1769.
16 IF 3,3
Verzemnieks, K., Tumelkans, R., Strautmane, S., Kalejs, V. R., Valeinis, E., Dolgopolova, J., Tone, T., & Balodis, A. (2025). Ruptured Intracranial Dermoid Cyst with Fat Dissemination: A Clinical Case Mimicking an Epidermoid Cyst and Review of the Literature. Diagnostics, 15(6), 712.
17 Q2 · IF 3,3
Balodis, A., Zālīte, S., Briede, I., Nazarovs, J., Jaunozoliņa, L., Bergfelde, E., Rätsep, T., & Auslands, K. (2025). Unusual localization of pilocytic astrocytoma at the foramen of Monro mimicking a colloid cyst: a case report and literature review. Frontiers in Oncology, 15, Article 1717175.
18 Q2 · IF 3,2
Bitiņa-Barlote, Ē., Bļizņuks, D., Silina, S., Šatcs, M., Vjaters, E., Lietuvietis, V., Nakazawa (Miklasevica), M., Plonis, J., Miklaševičs, E., Daneberga, Z., & Gardovskis, J. (2025). Liquid Biopsy Based Bladder Cancer Diagnostic by Machine Learning. Diagnostics, 15(4), Article 492.
19 Q2 · IF 3,2
Kuzņecova, E., Nakazawa (Miklasevica), M., Kriķe, N., Šatcs, M., Sīviņa, E., Irmejs, A., Loža, P., Gardovskis, J., Miklaševičs, E., & Daneberga, Z. (2025). The Transcriptomic Profile Underlying Somatic Monoallelic BRCA1 Inactivation: A Biomarker for Breast Cancer Prognosis. Diagnostics, 15(16), Article 2037.
20 Q2 · IF 3,2
Karhu, M., Tumelkans, R., Dzirkale, D., Auslands, K., Özütemiz, C., Flintere-Flinte, A., & Balodis, A. (2025). Tumefactive Demyelinating Lesion Mimicking Low-Grade Astrocytoma with a T2/FLAIR Mismatch Sign: A Case Report and Review of the Literature. Diagnostics, 15(24), Article 3174.
21 Q1 · IF 2,7
Bērza, N., Stars, I., Žodžika, J., Ķīvīte-Urtāne, A., Pärna, K., Uuskula, A., & Makejeva, D. (2025). Understanding hesitancy: barriers to HR-HPV self-sampling among women at high risk for cervical cancer in Latvia. BMC Women’s Health. Advance online publication.
22 Q2 · IF 2,7
Kokaine, L., Daneberga, Z., Šatcs, M., Zvina, D., Naļivaiko, I., Nazarovs, J., Gardovskis, A., Nakazawa (Miklasevica), M., & Miklaševičs, E. (2025). The Prognostic Role of microRNAs 142-5p, 182-3p, and 99a-3p in Locally Advanced Rectal Cancer Patients. Anticancer Research, 45(9), 3895–3912.
23 IF 2,6
Niedra, H., Rogoza, O., Saksis, R., Peculis, R., Halilova, A., Gerina, A., Vilisova, S., Senterjakova, N., Pukitis, A., Ruz-Caracuel, I., Earl, J., Kolnikova, G., Dubovan, P., Tomas, M., Makovicky, P., Urbanova, M., Smolkova, B., Koniaris, E., Aggelioudaki, I., Kataki, A., & Rovite, V. (2025). Transcriptomic profiling of pancreatic neuroendocrine tumors: dysregulation of WNT, MAPK, PI3K, neddylation pathways and potential non-invasive biomarkers. PLoS ONE, 20(6), e0325672.
24 IF 2,4
Kütner, S., Ozoliņš, A., & Gulla, A. (2025). Achieving quality and standards in Hepato-Pancreato-Biliary surgery: the Baltic chapter of E-AHPBA framework. HPB, 27, 1597–1599.
25 Q1 · IF 2,0
Mezeckis, M., Buryk, V., Vjaters, E., Skromanis, M., Strutinska, S., Ledina, S., & Svarinska, D. (2025). Primary Localized Prostate Cancer Treatment with Robotic Five-Fraction Ultra-Hypofractionated Radiotherapy: A Single-Center Experience. Scandinavian Journal of Urology, 60(Suppl. 223), Article AS-2.024.
26 Q3 · IF 1,6
Loginova, V., Mikijanskis, R., Krišāne, D., Briede, I., Štrumfa, I., & Balodis, A. (2025). Recurrent Angiomatous Meningioma in a Young Adult: A Case Report. American Journal of Case Reports, 26, Article e947185.
27
Vasiļčenko, I., Čēma, I., & Bāgante, I. (2025). Adjuvant A-PRF Application in Patients with Various Stages of Medication-Related Osteonecrosis of the Jaw (MRONJ). Case Series. Reports, 8(4), Article 240.
28
Rone, A. E., Bāgante, I., Vasilcenko, I., Zariņš, J., Deksnis, R., & Hasnere, S. (2025). Mandibular chondroblastic type osteosarcoma primarily diagnosed as chondrosarcoma as a result of radiation therapy: a case report. International Journal of Scientific Reports, 11(3), 139–143.
29
Brokāns, A., Dolgopolova, J., Saulitis, A., Spulle, U., Rancans, K., Meiers, D., Hasnere, S., & Balodis, A. (2025). Differential Diagnostic Challenges in Evaluation of Optic Nerve Glioblastoma with Extensive Spread to the Anterior Cranial Fossa. 191. Abstract from RSU Research Week 2025, Rīga, Latvia.
30
Ničiporuka, R., Veinberga, L., Cisco, R., Lin, D., Seib, C., King, J. M., Earley, M., Abreo, A., Myers, A., Ozoliņš, A., Narbuts, Z., Gardovskis, J., & Kebebew, E. (2025). Surgical Management of Thyroid Cancer Across Two Continents: Insights from Resource Distinct Centers. 181. Poster session presented at the 11th Conference of the European Society of Endocrine Surgeons, Izmir, Turkey.
31
Heinrihsone, R., Rate, M., Bitiņa-Barlote, Ē., Plonis, J., Miklaševičs, E., & Nakazawa (Miklasevica), M. (2025). Evaluating BCG Therapy in High- and Low-Grade Non-Muscle-Invasive Bladder Cancer: Insights from a Latvian Hospital (2019–2024). Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences, 79(3/4), 198–204.
32
Murane, N., Ivanova, J., Sklevska, A., Aleksejeva, J., Kozirovskis, V., Pukitis, A., & Zalizko, P. (2025). Clinical and diagnostic challenges in primary splenic lymphomas: when is splenectomy necessary to differentiate SMZL from DLBCL? European Journal of Case Reports in Internal Medicine, 12, Article 005686.
33
Eva Mediņa. Evaluating the Effect of Intravitreal Anti-VEGF Treatment on Radiation-Induced Maculopathy in Choroidal Melanoma Patients. Rīga Stradiņš University International Research Conference on Medical and Health Care Sciences “Knowledge for Use in Practice”, 2025. gada 26.–28. marts.
34
Dairis Meiers. Management of uveal melanoma in Latvia 2022–2025. A review. Forum Ophthalmologicum Balticum 2025, 2025. gada 15.–16. augusts, Rīga.
2024. gada publikācijas
1 IF 41,9
Saad, F., Vjaters, E., Shore, N., Olmos, D., Xing, N., Pereira De Santana Gomes, A. J., De Andrade Mota, A. C., Salman, P., Jievaltas, M., Jakubovskis, M., Kopyltsov, E., Han, W., Nevalaita, L., Testa, I., Le Berre, M.-A., Kuss, I., Haresh, K. P., Ganju, V., Gurney, H., Krieger, L., Kwatra, V., Sewak, S., Stevanovic, A., Weickhardt, A., Azambuja, A., Carcano, F. M., Costa, M. V., Cruz, F., De Menezes, J., Joseph De Padua, C. A., De Paula, A. A., Santiago Escovar, C. E., Couto Fernandez, F. L., Gampel, O., Luz, M., Marinho Dos Santos, G., Nogueira, L., D’Almeida Preto, D., Sant’anna, A., Tiscoski, K. A., Giddens, J., Jansz, G., Kim, J., Quellette, P., Vrabec, G., Gaete, A. A., Medina, C. C., Cruzat, J. D., Salvo, M. G., Pastor Arroyo, P. O., Huerta, A. S., Boghikian, P. S., Valenzuela Velasquez, Y. D., Zwenger, A., Fu, C., Guo, H., Jiang, H., Jiang, J., Jiang, S., Li, L., Liu, T., Liu, Z., Ma, L., Qi, J., Qiu, M., Shi, G., Tian, Y., Wan, B., Wang, C.-X., Wang, D., Wang, S., Wang, X., Wei, S., Wu, J., Xiao, J., Xie, K., Xie, L., Xue, B., Yan, Z., Yang, Y., Yu, Z., Zhang, D., Zheng, S., Zhou, F., Advani, S., Agarwal, P., Bhatt, N., Biswajit, D., Biswas, G., Bondarde, S. A., Das, C., Majumdar, S. D., Gupta, S., James, F., Jeyaraj, P., Joshi, A., Kalyan, S., Kashyapi, B., Kaushal, A., Krishnappa, R., Mavuduru, R., Nagarkar, R., Panchal, H., Parkash, G., Philips, A., Pooleri, G. K., Prabha, V., Rathnam, K. K., Ravel, N., Rawal, S., Reddy, B. R., Shah, M., Voonna, P., Aleksandrovs, A., Laukmanis, A., Lietuvietis, V., Vejins, M., Venckus, R., Zelvys, A., Bax, K., Gilling, P., Holmes, M., Tan, A., Deza, C. M. M., Pazos Franco, A. J., Salas Sanchez, J. F., Torrejon, A. F., Andabekov, T., Atduev, V., Chapko, Y., Fadeeva, N., Filippov, A., Gafanov, R., Gladkov, O., Kasparov, B., Kholtobin, D., Lykov, A., Nechaeva, M., Plekhanov, A., Safina, S., Semenov, A., Shkolnik, M., Skopin, P., Smirnov, R., Solovyeva, E., Sultanbaev, A., Zavyalov, M., Zyryanov, A., Chabane, K., Coetzee, C., Jacobs, C., Madlala, T., Malan, J., Mathijs, S., Abarca, C. L., Castellano Gauna, D. E., Alvarez-Ossorio Fernandez, J. L., Diaz, E. G., Garcia, P. B., Imbroda, B. H., Medina Lopez, R. A., Gaya Sopena, J. M., Chung, H.-J., Huang, S.-P., Tsai, Y.-S., Wang, P.-F., Wang, S.-S., Bondarenko, I., Golovko, Y., Ivashchenko, P., & Paramonov, V. (2024). Darolutamide in Combination With Androgen-Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer From the Phase III ARANOTE Trial. Journal of Clinical Oncology, 42(18).
2 IF 13
Irmejs, A., Garza, C., Evans, G., Soukupova, J., Plichta, J., Ngeow, J., Metcalfe, K., Lee, M., Bernstein-Molho, R., Yerushalmi, R., Fruscio, R., & Narod, S. (2024). Surgical Treatment of Women with Breast Cancer and a BRCA1 Mutation: An International Analysis of the Impact of Bilateral Mastectomy on Survival. Cancer Research, 84(9 Supplement).
3 IF 6
Vjaters, E., Fizazi, K., James, N. D., Tammela, T. L., Matsubara, N., Priou, F., Beuzeboc, P., Lesimple, T., Garcia, J. A., Aspegren, J., Jones, R. H., Bono, P., Kataja, V., Protheroe, A., Shore, N., Joensuu, H., Kuss, I., & Fiala-Buskies, S. (2024). Safety and tolerability of long-term treatment with darolutamide in patients with metastatic castration-resistant prostate cancer. Prostate Cancer and Prostatic Diseases, 27, 786–789.
4 IF 6
Irmejs, A., Renieri, A., Blatnik, A., Mensenkamp, A., Jahn, A., Colas, C., Houdayer, C., Bosch, D., Leter, E., Tham, E., Woodward, E., Innella, G., Brems, H., Vos, J., Schuurs-Hoeijmakers, J., Brunet, J., Balmana, J., Dupont, J., Verbeek, K., Jorgensen, K., Foretova, L., Hendricks, L., Olderode-Berends, M., Tischkowitz, M., Tveit Haavind, M., Genuardi, M., Hoogerbrugge, N., Benusiglio, P., Hueneburg, R., de Putter, R., Briskemyr, S., & Steinke-Lange, V. (2024). Cancer prognosis in PTEN Hamartoma Tumor Syndrome – a European cohort study. European Journal of Human Genetics, 32(Suppl. 1), 563–564.
5 IF 6
Shore, N. D., Gratzke, C., Feyerabend, S., Werbrouck, P., Carles, J., Vjaters, E., Tammela, T. L. J., Morris, D., Aragon-Ching, J. B., Concepcion, R. S., Emmenegger, U., Fleshner, N., Grabbert, M., Lietuvietis, V., Mahammedi, H., Cruz, F. M., Paula, A., Pieczonka, C., Rannikko, A., Richardet, M., Silveira, G., Kuss, I., Le Berre, M.-A., Verholen, F., Sarapohja, T., Smith, M. R., & Fizazi, K. (2024). Extended Safety and Tolerability of Darolutamide for Nonmetastatic Castration-Resistant Prostate Cancer and Adverse Event Time Course in ARAMIS. The Oncologist, 29(7), 581–588.
6 IF 5
Lauricella, E., Vilisova, S., Chaoul, N., Giglio, A., D’Angelo, G., Porta, C., & Cives, M. (2024). The current status of somatostatin analogs in the treatment of neuroendocrine tumors and future perspectives. Expert Review of Neurotherapeutics.
7 IF 5
Nazarovs, J., Isaguliants, M., Sokolovska, L., Biserova, K., Dudorova, A., Krisane, D., Lindenberga, I., & Dubencovs, S. (2024). HPV positive cervical squamous cell carcinomas: association with expression of p16, p53 and Ki67. Virchows Archiv, 485(Suppl. 1), S289–S290.
8 IF 4,5
Niedra, H., Peculis, R., Saksis, R., Mandrika, I., Vilisova, S., Nazarovs, J., Breiksa, A., Gerina, A., Earl, J., Ruz-Caracuel, I., Rosas, M. G., Pukitis, A., Senterjakova, N., & Rovite, V. Tumor and α-SMA-expressing stromal cells in pancreatic neuroendocrine tumors have a distinct RNA profile depending on tumor grade. Molecular Oncology, 19(3), 659–681. Publicēts elektroniski 2024. gada 8. septembrī.
9 IF 4
Kovaļova, Ž., Lāce, B., & Bernāte, K. (2024). A first genetically proven case of factor VII deficiency in Latvian family. Haemophilia, 30(Suppl. 1), 159–160.
10 IF 4
Lejnieks, A., Skride, A., Rudzītis, A., Ģībietis, V., Bernāte, K., & Puriņš, R. (2024). Daratumumab in first-line combination treatment of AL amyloidosis: experience from Riga, Latvia. Amyloid: The Journal of Protein Folding Disorders, 31(Suppl. 1), S149.
11 IF 4
Kriķe, P., Appel, M. S., Shums, Z., Poļaka, I., Kojalo, I., Rudzīte, D., Tolmanis, I., Kiršners, A., Bogdanova, I., Aleksandravica, I., Norman, G. L., & Leja, M. (2024). Autoimmune gastritis serological biomarkers in gastric cancer patients. European Journal of Cancer Prevention, 33(1), 29–36.
12 IF 3,2
Grabovska, D., Strumfa, I., Ositis, J., Liepniece-Karele, I., Balodis, A., & Benign Notochordal Cell Tumours. (2024). Benign Notochordal Cell Tumours: Case Report and Literature Review. Diagnostics, 14(13), Article 1330.
13 IF 3,2
Buss, A., Radziņa, M., Liepa, M., Birkenfelds, E., Saule, L., Miculis, K., Mikelsone, M., & Vjaters, E. (2024). Role of Apparent Diffusion Coefficient Value and Apparent Diffusion Coefficient Ratio as Prognostic Factors for Prostate Cancer Aggressiveness. Diagnostics, 14(21), Article 2438.
14 IF 3
Ošiņa, J., Jurjāns, K., Kupčs, K., Rzajeva, T., Miglāne, E. (2024). A Rare Case of Cervical Spinal Arteriovenous Malformation: A Case Report. Medicina, 60(6), Article 1011.
15 IF 3
Tumova, A., Auslands, K., Millers, A., Priede, Z., Buks, M., Ozola, A., Ozoliņa, E., Bicāns, K., & Ulmanis, R. (2024). Association of Schimmelpenning Syndrome with Astrocytoma (WHO Grade 3): Case Report. Medicina, 60(10), Article 1688.
16 IF 3
Polita, B. S. D., Lapiņš, J., Ģīlis, A., Grucki, M., Irmejs, A., Gardovskis, J., Maksimenko, J. (2024). Evaluation of Breast Skin/Nipple-Areolar Complex Sensation and Quality of Life after Nipple-Sparing Mastectomy Followed by Reconstruction. Medicina, 60(10), Article 1655.
17 IF 3
Rubens, O., Bērziņa, S., Rozenbaha, A., Dansone, G., & Troshina, Y. (2024). Exploring the Non-Invasive Approaches to Carpal Tunnel Syndrome in Routine Clinical Practice: A Focus on the Role of Acetylcholinesterase Inhibitors. Medicina, 60(8), Article 1219.
18 IF 3
Lapiņš, J., Polita, B. S. D., Kalniņa, L., Grucki, M., Ozols, D., Ģīlis, A., Irmejs, A., Gardovskis, J., & Maksimenko, J. (2024). Novel Nipple Reinnervation Technique Using N. Suralis Graft. Medicina, 60(9), Article 1533.
19 IF 3
Brokāns, A., Dolgopolova, J., Saulītis, A., Spulle, U., Rancāns, K., Meiers, D., Hasnere, S., & Balodis, A. (2024). Optic Nerve Glioblastoma with Optic Chiasm Involvement: A Case Report and a Brief Literature Review. Medicina, 60(10), Article 1687.
20 IF 3
Bitiņa-Barlote, Ē., Plonis, J., Andrejeva, M., Vjaters, E., Gardovskis, J., Daneberga, Z., Miklaševičs, E., & Nakazawa-Miklaševiča, M. (2024). Profiles of urinal exosomal miRNAs derived from bladder cancer. Central European Journal of Urology, 77(3), 361–374.
21 IF 3
Radziņa, M., Tirāne, M., Roznere, L., Zemniece, L., Dronka, L., Kalniņa, M., Mamis, E., Biederer, J., Lietuvietis, V., Freimanis, A., & Vjaters, E. (2024). Erratum: Accuracy of 68Ga-PSMA-11 PET/CT and multiparametric MRI for the detection of local tumor and lymph node metastases in early biochemical recurrence of prostate cancer. American Journal of Nuclear Medicine and Molecular Imaging, 14(3), 189.
22 IF 3
Šlisere, B., Straupmane, D., Bernāte, K., Romanovska, M., Saveļjeva, O. (2024). Ascites as the first presentation of plasmablastic lymphoma in HIV positive individual. Laboratorinė Medicina, 26(Suppl.).
23 IF 3
Nazarovs, J., & Mezals, A. (2024). Lung adenocarcinoma and squamous cell carcinoma: epidemiological, morphological and immunohistochemical characteristics in 379 primary cases. Medicina, 60(Suppl. 1), 178.
24 IF 1,5
Balodis, A., Ņeverčika, V., Zavertjajeva, M., Mikijanskis, R., Kalniņa, M., Breikša-Vaivode, A., & Briede, I. (2024). Giant Myxopapillary Ependymoma with Multi-Site Neural Axis Metastases: A Rare Case with Suboptimal Outcome. American Journal of Case Reports, 25, Article e942392.
25 IF 1,5
Balodis, A., Lapse, D., Eglīte, E., Dolgopolova, J., Kalniņa, M., Raits, U., & Zarembo, Z. (2024). Ewing Sarcoma of the Lumbar Spine With Lung Metastases in a 20-Year-Old Adult: A Rare Case Report. American Journal of Surgery and Clinical Case Reports, 7(13), 1–8.
26 IF 0,7
Kokaine, L., Radziņa, M., Liepa, M., Geriņa-Bērziņa, A., Sīviņa, E., Nikolajeva, J., Gardovskis, A., Gardovskis, J., Miklaševičs, E. (2024). “Watch and Wait” Strategy in Rectal Cancer Patients with a Complete Clinical Response after Neoadjuvant Chemoradiation Therapy: A Single-Center Experience. Experimental Oncology, 46(1), 53–60.
27 IF nav norādīts
Štrumfa, I., Liepniece-Karele, I., Balodis, A., Grabovska, D., Brinkenfelds, E., & Bičevska, K. (2024). Benign Notochordal Cell Tumour of Vertebra: The Navigation of Diagnostic Challenges through Radiological and Histological Pathways. European Musculoskeletal Radiology Congress 2024.
28 IF nav norādīts
Edelmers, E., & Fišere, I. (2024). Deep Learning-Based Software for Automated Cell Detection and Counting in Whole-Slide Histological Image Analysis. 11th Baltic Morphology Meeting, 67.
29 IF nav norādīts
Kļaviņa, A., Bērtule, D., Semjonova, G., Dubiņina, E., Blumberga, M., Češuna, A., Syndyukov, E., Jermoļenko, G. F., Kundziņa, I., Augstkalne, K., & Balamovskis-Kalniņš, K. (2024). Digital physical activity monitoring of pediatric oncology patients using augmented reality interactive game elements. PREPARE – Play, Rights, and Experiences in Pediatric Care, 6.
30 IF nav norādīts
Balodis, A., Strautmane, S., Mežvinska, P., & Pavlovičs, S. (2024). Multinodular Vacuolating Neuronal Tumors: Symptomatic Presentation Versus Incidental Finding: Case Series and Literature Review. Reports, 7(4), 86.
31 IF nav norādīts
Hendricks, L. A. J., Verbeek, K. C. J., Schuurs-Hoeijmakers, J. H. M., Mensenkamp, A. R., Brems, H., de Putter, R., Anastasiadou, V. C., Villy, M.-C., Jahn, A., Steinke-Lange, V., Baldassarri, M., Irmejs, A., de Jong, M. M., Links, T. P., Leter, E. M., Bosch, D. G. M., Høberg-Vetti, H., Tveit Haavind, M., Jørgensen, K., Mæhle, L., Blatnik, A., Brunet, J., Darder, E., Tham, E., Hoogerbrugge, N., & Vos, J. R. (2024). Lifestyle Factors and Breast Cancer in Females with PTEN Hamartoma Tumor Syndrome (PHTS). Cancers, 16(5), Article 953.
32 IF nav norādīts
Jevdokimova, N., Jevdokimov, D., Ivanova, J., Isajevs, S., Staka, A., & Pukitis, A. (2024). A Young Female with a Hepatic Epithelioid Hemangioendothelioma. European Journal of Case Reports in Internal Medicine, 11(7).
33 IF nav norādīts
Markevičs, K., Basina, O., Pokrotnieks, J., & Lapiņa, A. (2024). Therapeutic Endoscopy Following Radical Treatment of Upper Gastrointestinal Tract Cancer. Proceedings of the Latvian Academy of Sciences, Section B: Natural, Exact, and Applied Sciences, 78, 283–289.
34 IF nav norādīts
Priedītis, P., Ozoliņš, A., Miķelsone, M., Radziņa, M., Liepa, M., Ničiporuka, R., Narbuts, Z., Pavlovičs, S., Ratniece, M. (2024). Multiparametric ultrasound in differentiating parathyroid adenoma from hyperplasia: a diagnostic advantage. 9th Baltic Congress of Radiology, 49.
2023. gada publikācijas
1 IF 25,3
Ērglis, A., Ferenc, M., Wlodarczak, A., Pan, M., Schmitz, T., Kretov, E., Chieffo, A., Darremont, O., Banning, A., Maznyczka, A., Hildick-Smith, D., Egred, M., Arunothayaraj, S., & Louvard, Y. (2023). Efficacy and Safety of Darolutamide in Patients with Nonmetastatic Castration-Resistant Prostate Cancer Stratified by Prostate-Specific Antigen Doubling Time: Planned Subgroup Analysis of the Phase 3 ARAMIS Trial.
2 IF 25,3
Kroiča, J., Asare, L., Pētersons, A., Rācenis, K., Žentiņa, D., Avotiņš, L., Saulīte, A. J., & Kravale, Z. (2023). Erratum to “Efficacy and Safety of Darolutamide in Patients with Nonmetastatic Castration-Resistant Prostate Cancer Stratified by Prostate-Specific Antigen Doubling Time: Planned Subgroup Analysis of the Phase 3 ARAMIS Trial”.
3 IF 10,0
Vasiljevs, D., Kakurina, N., Pontaga, N., Kokina, B., Osipovs, V., Sorokins, N., Pikta, S., Trušinskis, K., & Lejnieks, A. (2023). Efficacy and Safety Outcomes of Darolutamide in Patients with Non-Metastatic Castration-Resistant Prostate Cancer with Comorbidities and Concomitant Medications from the Randomised Phase 3 ARAMIS Trial.
4 IF 6,0
Tretjakovs, P., Gersone, G., Gailīte, L., Kurjāne, N., Vilne, B., Šlisere, B., Lucāne, Z., Straupmane, D., & Papirte, S. (2023). Transcriptome of GH-producing Pituitary Neuroendocrine Tumours and Models Are Significantly Affected by Somatostatin Analogues.
5 IF 4,5
Kauliņš, R., Rudzītis, A., Lejnieks, A., Kigitoviča, D., & Skride, A. (2023). Polygenic Risk Score Predicts Modified Risk in BRCA1 Pathogenic Variant c.4035del and c.5266dup Carriers in Breast Cancer Patients.
6 IF 3,1
Banach, M., Penson, P. E., Farnier, M., Fras, Z., Latkovskis, G., Laufs, U., Paneni, F., Parini, P., Pirro, M., Vrablik, M., & Escobar, C. (2023). Effects of BRAF V600E and NRAS Mutational Status on the Progression-Free Survival and Clinicopathological Characteristics of Patients with Melanoma.
7 IF 2,5
Vjaters, E., Radziņa, M., Liepa, M., Briede, I., Saule, L., Putriņš, D. S., Jukonis, J., Ratniece, M., & Maļika-Popova, Ņ. (2023). Can Intratumoural Vascularisation CT Contrast Dynamics Help Differentiate Malignant Renal Tumour Subtypes?
8 IF 2,5
Nartisa, R., Kirsteina, K. D., Neiburga, S., Žīgure, S., Ozola, L., Grantiņa, I., Mičule, I., Mūrmane, D., Šlisere, B., Gailīte, L., Vilne, B., Rots, D., Tauriņa, G., & Kurjāne, N. (2023). Diagnostic Difficulties in Immunosuppressed Patient with Suspected Primary Central Nervous System Lymphoma: Case Report.
9 IF 2,5
Nartisa, R., Kirsteina, K. D., Neiburga, S., Žīgure, S., Ozola, L., Grantiņa, I., Mičule, I., Mūrmane, D., Šlisere, B., Gailīte, L., Vilne, B., Rots, D., Tauriņa, G., & Kurjāne, N. (2023). Rare Case with Lumbar Ewing’s Sarcoma in Young Adult: Case Report.
10 IF 2,5
Kalniņa, M., Valante, R., & Lazdovska, K. (2023). Risk Factors for Recurrence of Renal Cell Carcinoma after Partial or Total Nephrectomy.
11 IF 2,5
Dubra, A. (2023). Utility of Multiparametric MRI ADC Values in Assessment of Prostate Cancer Gleason Score.
12 IF 2,5
Fröbert, O., Götberg, M., Erlinge, A., Akhtar, Z., Christiansen, E. H., MacIntyre, C. R., Oldroyd, K. G., Hlinomaz, O., Jakobsen, L., Kåregren, A., Lauermann, J., Nilsson, J., Persson, J., Stalby, P., Islam, A. K. M. M., Rahman, A., Motovska, Z., Moer, R., Engstrøm, T., Jensen, L. O., Fallesen, C. O., Jensen, S. E., Angerås, O., Calais, F., Mokhtari, A., Malik, F., Choudhury, S., Collier, T., Pocock, S. J., & Pernow, J. (2023). Vascularisation Patterns of Solid Renal Tumours: Differentiation of Benign and Malignant Renal Masses.
13 IF 2,3
Skuja, S., Birze, A., Brečs, I., & Grīnbergs, P. (2023). Sporadic Pancreatic Neuroendocrine Neoplasms: A Retrospective Clinicopathological and Outcome Analysis from a Latvian Study Group.
14 IF 2,1
Kistkins, S., Mihailovs, T., Lobanovs, S., Pīrāgs, V., Sourij, H., Moser, O., & Bļizņuks, D. (2023). Correction: Effectiveness of Secondary Risk-Reducing Strategies in Patients with Unilateral Breast Cancer with Pathogenic Variants of BRCA1 and BRCA2 Subjected to Breast-Conserving Surgery: Evidence-Based Simulation Study.
15 IF 2,1
Benedek, T., Wieske, V., Szilveszter, B., Kofoed, K. F., Donnelly, P., Rodriguez-Palomares, J., Ērglis, A., Veselka, J., Šakalyte, G., Adić, N. Č., Gutberlet, M., Diez, I., Davis, G., Zimmermann, E., Kępka, C., Vidakovic, R., Francone, M., Ilnicka-Suckiel, M., Plank, F., Knuuti, J., Faria, R., Schröder, S., Berry, C., Merkely, B., Gellér, L., Danesh, J., Mohamed, M., Martus, P., Haase, R., & citi. (2023). Effectiveness of Secondary Risk-Reducing Strategies in Patients with Unilateral Breast Cancer with Pathogenic Variants of BRCA1 and BRCA2 Subjected to Breast-Conserving Surgery: Evidence-Based Simulation Study.
16 IF 2,0
Vjaters, E., Miķelsone, M., Radziņa, M., Liepa, M., Bušs, A., Birkenfelds, E., & Miculis, K. (2023). Pathological Complete Response to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer – Single Hospital Experience.
17 IF 1,6
Krieviņš, D., Zellāns, E., Latkovskis, G., Kumsārs, I., Jēgere, S., & Ērglis, A. (2023). Intravenous Immunoglobulin Therapy-Induced Erythema Multiforme in a Patient with Chronic Lymphocytic Leukemia.
18 IF 1,6
Miklaševičs, E., Maksimenko, J., Nakazawa-Miklaševiča, M., Trofimovičs, G., Gardovskis, J., Pinto, D., Cardoso, F., & Pereira Rodrigues, P. (2023). Surgical Treatment of Hepatocellular Carcinoma with a Tumor Thrombus Invading the Right Atrium: A Case Report.
19 IF 1,2
Lucāne, Z., Kursīte, M., Šablinskis, K., Gailīte, L., Kurjāne, N., & Gailīte, L. (2023). Neuroendocrine Carcinoma of the Extrahepatic Bile Ducts: A Case Report.
20 IF 1,0
Lucāne, Z., Šlisere, B., Gersone, G., Papirte, S., Gailīte, L., Tretjakovs, P., & Kurjāne, N. (2023). Overview of the Current Role of Stereotactic Body Radiotherapy in the Treatment of Unfavorable Intermediate- and High-Risk Prostate Cancer.
21
Kuzņecova, E., Daneberga, Z., Berga-Švītiņa, E., Nakazawa-Miklaševiča, M., Irmejs, A., Gardovskis, J., & Miklaševičs, E. (2023). Identification of Altered Transcripts and Pathways in Triple Negative Breast Cancer. Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences, 77(1), 33–40.
22
Urtāne, I., Gavrilova, A., Ņikitina, A., Latkovskis, G., Meisters, J., Nemme, N., & Saveļjeva, O. (2023). Accuracy of Migraine Diagnosis and Treatment by Neurologists in the Baltic States: E-Survey with Clinical Case Challenge.
23
Veinberga, L., Meidrops, K., Rumba, R., Gediņš, M., Anufrijevs, D., Vilmanis, J., Drizlionoka, K., Zellāns, E., Krustiņa, I., Bērziņš, J., Briede, I., Radziņa, M., Ozoliņš, A., & Stradiņš, P. (2023). Hepatocelulāra karcinoma ar tumora trombu ieaugšanu labajā priekškambarī. Klīniskais gadījums. Latvijas Ārsts, Nr. 4, 36–38.
24
Kalniņa, M., Valante, R., & Lazdovska, K. (2023). Advancing Therapeutics for Recurrent Clostridioides difficile Infections: An Overview of Vowst’s FDA Approval and Implications.
25
Meļņikova, V., Valante, R., & Brige, S. (2023). Alerģisks rinīts un izaicinājumi ārstēšanā.
26
Voloudakis, N., De Crea, C., Sessa, L., Agcaoglu, O., Brunaud, L., Chiofalo, M. G., Hellmann, A., Koutelidakis, I., Makay, O., Narbuts, Z., Nastos, K., Pennestri, F., Vamvakidis, K., Vriens, M., Musholt, T. J., & Raffaelli, M. (2023). Advanced Medullary Thyroid Cancer in Europe: Results of a Multicenter Study Based on the EUROCRINE® Registry, 100–101.
27
Kokaine, L., Briede, I., Brikuns, A., Gardovskis, A., & Gardovskis, J. (2023). Primary Burkitt Lymphoma of the Rectum. Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences, 77(3–4), 211–216.
28
Berga-Švītiņa, E., Pirsko, V., Nakazawa-Miklaševiča, M., Maksimenko, J., Gardovskis, J., & Miklaševičs, E. (2023). Penetrance of CHEK2 and BRCA1 Double Heterozygotes in Breast and/or Ovarian Cancer Patients. Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences, 77(2), 137–140.
29
Hendricks, L., Verbeek, K., ... Irmejs, A. (2023). Cancer Prognosis in PTEN Hamartoma Tumor Syndrome – a European Cohort Study. European Journal of Human Genetics, 32, 563–564. Meeting abstract P13.055.C, 56th Annual Conference of the European Society of Human Genetics, 2023. gada 10.–13. jūnijs.
30
Balodis, A., Bičevska, K., Muravska, T., & Raits, U. (2023). Alteration in Serum Albumin, Magnesium, and Phosphorus Levels during Hemadsorption with oXiris in Critically Ill Patients with Septic Shock.
31
Ērglis, A., Pierre, B., Lau, D. H., Martens, E., Schrader, J., Cabanas, P., & Deneke, T. (2023). Alterations in Serum Albumin, Magnesium, and Phosphorus Levels during Hemadsorption with oXiris® in Critically Ill Patients with Septic Shock.
32
Šlisere, B., Arisova, M., Aizbalte, O., Salmiņa, M. M., Zolovs, M., Levenšteins, M., Mukāns, M., Troickis, I., Meija, L., Lejnieks, A., Bīlande, G., Rosser, E. C., & Oļeiņika, K. (2023). Antimicrobial and Defense Proteins in Chronic Rhinosinusitis with Nasal Polyps.
33
Lihacova, I., Balmages, I., Reinis, A., Kistkins, S., Bļizņuks, D., Plorina, E. V., Ļihačovs, A., & Lihacova, I. (2023). A Pilot Study to Evaluate a Novel Localized Treatment to Stabilize Small- to Medium-Sized Infrarenal Abdominal Aortic Aneurysms.
34
Vukovic, N., Meier, R., Guligowska, A., Zalizko, P., & Meier, R. (2023). A Pilot Study to Evaluate a Novel Localized Treatment to Stabilize Small- to Medium-Sized Infrarenal Abdominal Aortic Aneurysms.
35
Maksimenko, J., Pereira Rodrigues, P., Nakazawa-Miklaševiča, M., Pinto, D., Trofimovičs, G., Gardovskis, J., & Cardoso, F. (2023). Approaching Automated COPD Treatment Based on Markov Decision Process.
36
Zablocka, T., Kreismane, M., Pjanova, D., & Isajevs, S. (2023). A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Assess Safety, Tolerability, and Efficacy of RT001 in Patients with Amyotrophic Lateral Sclerosis.
37
Trušinskis, K., Knoka, E., Jēgere, S., Lapsovs, M., Ērglis, A., Kokina, B., Sondore, D., Kumsārs, I., Narbute, I., Caunīte, L., & Karantajere, M. (2023). Association of Brain MRI Volumetry Results with Changes in EDSS among Patients with Multiple Sclerosis during a 5-Year Follow-Up.
38
Vjaters, E., Bögemann, M., Shore, N. D., Smith, M. R., Tammela, T. L. J., Ulys, A., Polyakov, S., Jievaltas, M., Luz, M., Alekseev, B., Lebret, T., Schostak, M., Verholen, F., Le Berre, M.-A., Srinivasan, S., Ortiz, J., Mohamed, A. F., Sarapohja, T., & Fizazi, K. (2023). Association of Endotoxemia with Low-Grade Inflammation, Metabolic Syndrome and Distinct Response to Lipopolysaccharide in Type 1 Diabetes.
39
Vjaters, E., Fizazi, K., Bögemann, M., Smith, M. R., Shore, N. D., Tammela, T. L. J., & Sarapohja, T. (2023). Bailout Inclisiran-Based Triple Lipid-Lowering Therapy Reduces Plaque Lipid Content in Stable Coronary Artery Disease Patients.
40
Vjaters, E., Fizazi, K., Shore, N. D., Smith, M., Ramos, R., Jones, R., Niegisch, G., Wang, Y., Srinivasan, S., Sarapohja, T., & Verholen, F. (2023). Baseline Clinical Characteristics and Incidence of Chronic Thromboembolic Pulmonary Hypertension Patients in Latvia, 2019–2020.
41
Chorostowska-Wynimko, J., Barila, R., Jaal, J., Kirova-Nedyalkova, G., Krejci, J., Ostoros, G., Petrova, M., Pluzanski, A., Pop, O., Skrickova, J., Spaks, A., Stanculeanu, D. L., Lupu, R., Teodorescu, G., & Ryska, A. (2023). HSD57 The Actionable Gaps of the Journey of Patients with Lung Cancer. Value in Health, 25(12), S284.
42
Petrovs, A., & Spaks, A. (2023). Treatment of Endobronchial Tumors Using Cryotherapy (CRT). Medicina, 59(Supplement 2), 703.
43
Voloudakis, N., De Crea, C., Sessa, L., Agcaoglu, O., Brunaud, L., Chiofalo, M. G., Hellmann, A., Koutelidakis, I., Makay, O., Narbuts, Z., Nastos, K., Pennestri, F., Vamvakidis, K., Vriens, M., Musholt, T. J., & Raffaelli, M. (2023). Advanced Medullary Thyroid Cancer in Europe: Results of a Multicenter Study Based on the EUROCRINE® Registry, 100–101.
